Jazz Pharmaceuticals
JAZZ
JAZZ
323 hedge funds and large institutions have $7.32B invested in Jazz Pharmaceuticals in 2017 Q4 according to their latest regulatory filings, with 63 funds opening new positions, 101 increasing their positions, 105 reducing their positions, and 40 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
323
Holders Change
+20
Holders Change %
+6.6%
% of All Funds
7.34%
Holding in Top 10
6
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+20%
% of All Funds
0.14%
New
63
Increased
101
Reduced
105
Closed
40
Calls
$16.5M
Puts
$51.9M
Net Calls
-$35.4M
Net Calls Change
-$55K
Top Buyers
| 1 |
Boston Partners
Boston,
Massachusetts
|
$161M |
| 2 |
Bank of New York Mellon
New York
|
$237M |
| 3 |
Balyasny Asset Management
Chicago,
Illinois
|
$35.7M |
| 4 |
AL
AJO LP
Philadelphia,
Pennsylvania
|
$24.5M |
| 5 |
Goldman Sachs
New York
|
$102M |
